

Is there a Dovato shortage in 2026? Get the latest update on Dovato availability, pricing, and what you can do if your pharmacy is out of stock.
If you take Dovato for HIV, you may have heard rumors about a shortage — or worse, experienced it firsthand when your pharmacy told you they couldn't fill your prescription. It's understandable to feel anxious when a medication you depend on every day seems hard to get.
In this article, we'll give you the most current information about Dovato's availability in 2026, explain why it can be difficult to find, and share practical steps to make sure you don't miss a dose.
As of early 2026, Dovato is not listed on the FDA's official drug shortage database. This means the manufacturer, ViiV Healthcare, is producing and distributing Dovato normally.
However, "not in shortage" doesn't always mean "easy to find." Many patients still report difficulty picking up Dovato at their local pharmacy. The disconnect comes down to how specialty medications are stocked and distributed — which we'll explain below.
Even without a formal shortage, several factors can make Dovato difficult to locate:
Dovato is a specialty HIV medication with a retail price of approximately $2,000 to $2,800 per month. Many retail pharmacies only order it when a patient requests it, rather than keeping it on the shelf. This means there can be a delay of 1-3 business days while the pharmacy orders it from their distributor.
Unlike common medications such as blood pressure pills or antibiotics, not every pharmacy stocks HIV antiretrovirals. Chain pharmacies may carry Biktarvy (the most prescribed HIV medication) but not necessarily Dovato. Learn more about why Dovato is hard to find.
Prior authorization requirements from insurance companies can add days to the process. If your plan requires prior auth for Dovato, the pharmacy can't dispense it until approval comes through.
Understanding the cost landscape helps explain some of the access challenges:
For detailed savings strategies, check out our guide on how to save money on Dovato in 2026.
The HIV treatment landscape continues to evolve. While Dovato remains an excellent option, you should know about other approaches:
If you're interested in exploring alternatives, read our full guide on alternatives to Dovato. But remember — never switch medications without your doctor's guidance.
Here are the most effective strategies for getting your Dovato prescription filled:
Medfinder is a free tool that shows you which pharmacies near you have Dovato in stock right now. It's the fastest way to avoid calling around and waiting on hold.
Pharmacies that specialize in HIV medications are far more likely to keep Dovato on hand. Ask your HIV care provider which specialty pharmacies they recommend.
Many insurance plans offer specialty mail-order services. Medications are delivered to your door, often with automatic refills so you never run out.
Request your refill at least 7 days before you run out. If your pharmacy needs to order Dovato, this gives them time to get it in stock.
ViiV Healthcare's patient support line (1-844-588-3288) can help you locate pharmacies with Dovato in stock and connect you with savings programs. For more tips, see our guide on how to find Dovato in stock near you.
While Dovato is not in a formal shortage as of 2026, the realities of specialty drug distribution mean that finding it isn't always straightforward. The most important thing you can do is plan ahead, use tools like Medfinder, and maintain open communication with your healthcare provider.
HIV treatment has come a long way, and you have more options than ever for staying healthy. Don't let a pharmacy stocking issue derail your progress — be proactive, use the resources available to you, and keep your viral load undetectable.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.